Latest Breaking News On - Sairiyo therapeutics inc - Page 7 : comparemela.com

Pharmadrug Inc.: PharmaDrug Advances Product and Clinical Development of Cepharanthine to Treat Rare Cancers and Infectious Diseases PharmaDrug or the Company ), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs, is pleased to announce that the Company has entered into an agreement with Southwest Research Institute® ( SwRI® ), to initiate non-clinical and clinical manufacturing of Cepharanthine for the Company s rare cancer and infectious diseases programs. In connection with PharmaDrug s recent acquisition of Sairiyo Therapeutics Inc., the Company has secured an exclusive license from SwRI to develop and commercialize a novel oral formulation of Cepharanthine for all fields of use as well as exclusive rights to U.S. Patent: 10,576,077, titled Pharmaceutical Salt forms of Cepharanthine and Tetrandrine . Formalization o

United statesJapan generalBaden wübergDaniel cohenBaillyc cepharanthineSairiyo therapeutics incNewsfile corpSchedulei european unionResearch institutePharmadrug incHealth canadaSouthwest research instituteDrug designationMiddle eastPharmadrug production gmbhSuper smart